A recent survey shows payers migrating toward a value-based reimbursement model, but clear discrepancies exist among adoption rates.

Utah's plan for a slimmed-down Medicaid expansion includes unprecedented annual limits on federal and state spending.

When it comes to addressing some of the biggest issues in healthcare, e-prescribing company Surescripts has a big potential role to play.

John Noseworthy, M.D., former CEO of Mayo Clinic, has joined the board of directors at UnitedHealth Group, plus more insurance news.

The Medicare at 50 Act, introduced earlier this week, is already getting pushback from healthcare organizations.

Democrats in are now putting a spotlight on so-called junk insurance plans touted by the Trump administration.

The Trump administration is making transparency a “priority” as it embraces policies like step therapy, according to a top CMS official.

Democrats have officially revealed a plan to let people ages 50 and over buy in to Medicare, plus more insurance news.

The number of FDA-approved therapies for personalized medicines has jumped from 20% to 40% in the last few years.